APA (7th ed.) Citation

Hu, N., Xiao, F., Chen, Y., Gu, Q., Liang, P., Xu, Y., . . . Zhang, H. (2025). Efficacy, Safety, and Cost-Effectiveness Analysis of Ceftazidime-Avibactam versus Polymyxin B in the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections: A Target Trial Emulation. Infectious Diseases & Therapy, 14(7), 1419. https://doi.org/10.1007/s40121-025-01164-9

Chicago Style (17th ed.) Citation

Hu, Na, et al. "Efficacy, Safety, and Cost-Effectiveness Analysis of Ceftazidime-Avibactam Versus Polymyxin B in the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections: A Target Trial Emulation." Infectious Diseases & Therapy 14, no. 7 (2025): 1419. https://doi.org/10.1007/s40121-025-01164-9.

MLA (9th ed.) Citation

Hu, Na, et al. "Efficacy, Safety, and Cost-Effectiveness Analysis of Ceftazidime-Avibactam Versus Polymyxin B in the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections: A Target Trial Emulation." Infectious Diseases & Therapy, vol. 14, no. 7, 2025, p. 1419, https://doi.org/10.1007/s40121-025-01164-9.